Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Bio-Rad (BIO) Q4 2025 Earnings Call Transcript

Amid a monster year and, more recently, a transformative deal announcement, this move raises a sharper question about how much upside is really left at today’s valuation.

Payoneer just posted record revenue and raised guidance, yet one fund trimmed its stake. The disconnect is where the real story is.

The company doesn't seem like it will generate pops in key fundamentals anytime soon.

Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent strategic developments. This significant uptick reflects investor confidence in the life sciences giant's aggressive expansion into high-growth sectors,

Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.

Stocks are headed for weekly gains, with the Dow Jones dipping slightly and the S&P 500 and Nasdaq trading just above the flatline Friday.

History says Palantir stock could soar after its inclusion in the S&P 500.